Randomized Phase II Study Comparing Dose Escalated Weekly Paclitaxel vs. Standard Dose Weekly Paclitaxel for Patients with Previously Treated Advanced Gastric Cancer-Reference-Cited by-同舟云学术

Randomized Phase II Study Comparing Dose Escalated Weekly Paclitaxel vs. Standard Dose Weekly Paclitaxel for Patients with Previously Treated Advanced Gastric Cancer

Published:2010-11-09 Issue:2 Volume:41 Page:287-290
ISSN:0368-2811
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:Japanese Journal of Clinical Oncology

Author:

Shitara K.,Oze I.,Mizota A.,Kondo C.,Nomura M.,Yokota T.,Takahari D.,Ura T.,Yuki S.,Komatsu Y.,Matsuo K.,Muro K.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/41/2/287/5134552/hyq206.pdf

Reference13 articles.

1. Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer

2. Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

3. Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial

4. How to calculate the dose of chemotherapy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Chemotherapy-Induced Neutropenia on Overall Survival in Patients With Unresectable or Metastatic Urothelial Carcinoma to Gemcitabine Plus Cisplatin Combination Chemotherapy;Annals of Pharmacotherapy;2019-02-08

2. Cost-effectiveness and safety of ramucirumab plus paclitaxel chemotherapy in the treatment of advanced and recurrent gastric cancer;Journal of Oncology Pharmacy Practice;2017-04-24

3. Safety and continuity of second- and third-line therapy with paclitaxel or irinotecan for advanced and recurrent gastric cancer;Molecular and Clinical Oncology;2014-02-14

4. Effect of the Weekly Administration of Liposome–Paclitaxel Combined with S-1 on Advanced Gastric Cancer;Japanese Journal of Clinical Oncology;2014-01-22

5. Pharmacokinetics of Carbon Nanoparticle-Paclitaxel Suspension for Use in Intraperitoneal Chemotherapy;HEPATO-GASTROENTEROL;2013